Cherkashin S Iu, Nagornaia I N, Tananko E M, Dymshits L B, Nosikova T A
Ter Arkh. 1989;61(7):95-7.
3-Methoxybenzathrone (MBA) fluorescence was used to explore the structural properties of blood lymphocyte membranes in patients with atopic bronchial asthma and pollenosis treated by specific immunotherapy. An analysis was made of the relationship between the changes in MBA fluorescence and the blood counts of T and B lymphocytes as well as the clinical efficacy of the treatment. As a result of the treatment, the patients manifested an appreciable increase in the MBA fluorescence intensity towards normal and higher limits, provided the results of the treatment were beneficial. In case the treatment effect was unsatisfactory, MBA fluorescence diminished. The rise of MBA fluorescence in lymphocytes was not induced by the changes in the cell counts in the populations. The treatment effect on the membranes remained unchanged in subsequent exacerbation. The use of MBA permits an objective and early assessment of the results of specific immunotherapy.
采用3-甲氧基苯并蒽酮(MBA)荧光法探究特异性免疫疗法治疗的特应性支气管哮喘和花粉症患者血淋巴细胞膜的结构特性。分析了MBA荧光变化与T、B淋巴细胞计数变化以及治疗临床疗效之间的关系。治疗结果显示,若治疗效果良好,患者的MBA荧光强度明显升高至正常及更高水平;若治疗效果不理想,MBA荧光则减弱。淋巴细胞中MBA荧光的升高并非由细胞群体数量变化所致。在后续病情加重时,治疗对细胞膜的效果保持不变。使用MBA可对特异性免疫疗法的结果进行客观且早期的评估。